Position in ACAD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$10,931,730
-$5,656,488 QoQ
Shares Held
491,093
-20.9% QoQ
Ownership
0.287%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JUPITER ASSET MANAGEMENT LTD holds $304,105,196 across 12 Biotechnology names. ACAD ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
1,608,256 | $103,941,584 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
711,457 | $48,471,564 | |
| 3 | INCY |
Incyte Corp
|
482,642 | $45,426,264 | |
| 4 | EXEL |
Exelixis, Inc.
|
967,409 | $41,492,171 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
1,781,063 | $22,833,227 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
803,419 | $11,906,668 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
491,093 | $10,931,730 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
274,419 | $6,794,614 |
All Filings in ACAD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,931,730 | 491,093 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,588,218 | 621,049 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $10,164,604 | 476,317 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,726,608 | 636,375 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,761,117 | 407,051 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $2,421,688 | 157,457 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $17,238,649 | 1,060,840 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $29,653,780 | 1,603,774 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $41,403,216 | 1,322,364 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $26,596,341 | 1,276,216 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $30,447,250 | 1,271,284 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $25,738,250 | 1,367,601 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $17,352,353 | 1,089,972 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,264,496 | 77,292 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $916,117 | 65,019 | Shares | Defined | 2022-08-10 | |
| 2020-09-30 | $4,795,642 | 116,258 | Shares | Defined | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||